Search results for "Venous thromboembolism"


 
Results 61 - 70 of about 338 for "Venous thromboembolism".
Sort by: Relevance | Newest | Oldest

Adding aspirin or NSAID to anticoagulant doubles bleeding risk

Taking aspirin or an NSAID while on anticoagulant therapy is associated with an increased risk of bleeding in patients who have had a venous thromboembolism (VTE), a recent study found.
https://acphospitalist.acponline.org/weekly/archives/2014/04/23/1.htm
23 Apr 2014

New studies assess effects of anticoagulation during, after COVID-19

Use of intermediate, full-dose, or prophylactic anticoagulation in COVID-19 inpatients wasn't associated with any difference in in-hospital mortality in one study, while another found it was safe to discontinue anticoagulation after three months in patients with a COVID-19-associated clot.
https://acphospitalist.acponline.org/archives/2022/11/16/free/new-studies-assess-effects-of-anticoagulation-during-after-covid-19.htm
16 Nov 2022

Letter from the Editor

This month's issue includes articles on the optimal use of prophylaxis for venous thromboembolism, differential diagnoses for Ebola, and conference coverage.
https://acphospitalist.acponline.org/archives/2015/01/lfe.htm
15 Jan 2015

Just don't do it

Leonard Feldman, MD, FACP, takes a look at non-evidence-based medicine.
https://acphospitalist.acponline.org/archives/2013/08/conf01.htm
15 Aug 2013

Higher-dose prophylactic anticoagulation required to prevent thrombosis in hypoxemic COVID-19

Mortality and time to improvement didn't differ with twice the standard dose of heparin versus a standard or therapeutic dose, but there was a lower rate of new thromboembolic events with no increase in major bleeding, a French trial found.
https://acphospitalist.acponline.org/archives/2023/03/29/free/higher-dose-prophylactic-anticoagulation-needed-to-prevent-thrombosis-in-hypoxemic-covid-19.htm
29 Mar 2023

Review finds 18% mortality in severe DOAC-related bleeding treated with reversal agent

A systematic review looked at 60 studies that evaluated four-factor prothrombin complex concentrates, idarucizumab, or andexanet for the treatment of severe or uncontrolled bleeding in patients on a direct oral anticoagulant (DOAC).
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/4.htm
16 Jun 2021

July 2009

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2009/07/

New recommendations cover preop management of endocrine, hormonal, urologic medications

The guidance from the Society for Perioperative Assessment and Quality Improvement focused on long-term medications and prioritized avoiding interruption of therapy unless continuation poses risks.
https://acphospitalist.acponline.org/weekly/archives/2021/03/17/2.htm
17 Mar 2021

June 28, 2023

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2023/06/28/

Active strategy to diagnose PE in COPD inpatients did not improve outcomes

A Spanish trial found that using d-dimer testing and, if positive, a CT pulmonary angiogram to diagnose pulmonary embolism (PE) did not affect risk of death, clot, or readmission in patients hospitalized for exacerbation of chronic obstructive pulmonary disease (COPD).
https://acphospitalist.acponline.org/weekly/archives/2021/10/20/3.htm
20 Oct 2021

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next